Figure 2.
Unadjusted Cumulative Risks of the Study Outcomes
Event rates are shown with the use of Kaplan-Meier estimates of the rates of (A) the primary composite end point and the individual components of the primary end point, ie, (B) death from any cause, (C) stroke, and (D) rehospitalization, in patients who underwent rapid-deployment aortic-valve replacement (Sutureless/RD-AVR), surgical aortic valve replacement (SAVR), and transcatheter aortic valve replacement (TAVR).